ChemicalBook >> CAS DataBase List >>LQZ-7I

LQZ-7I

CAS No.
195822-23-2
Chemical Name:
LQZ-7I
Synonyms
LQZ-7I;N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine;2,3-Quinoxalinediamine, N2,N3-bis(4-fluorophenyl)-;LQZ7I,inhibit,Survivin,LQZ 7I,Inhibitor,tumor,LQZ-7I,dimerization
CBNumber:
CB56193512
Molecular Formula:
C20H14F2N4
Molecular Weight:
348.35
MDL Number:
MFCD00607076
MOL File:
195822-23-2.mol
Last updated:2024-07-02 08:55:11

LQZ-7I Properties

Melting point 203 °C(Solv: ethanol (64-17-5))
Boiling point 470.3±45.0 °C(Predicted)
Density 1.390±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,Room temperature
solubility DMSO: 125 mg/mL (358.83 mM)
form A solid
pka 2.56±0.59(Predicted)
color Light yellow to green yellow

SAFETY

Risk and Safety Statements

LQZ-7I price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Ambeed A1275711 N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine 98+% 195822-23-2 1mg $58 2021-12-16 Buy
Arctom AS711703 N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine ≥98% 195822-23-2 5mg $89 2021-12-16 Buy
Ambeed A1275711 N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine 98+% 195822-23-2 5mg $90 2021-12-16 Buy
Arctom AS711703 N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine ≥98% 195822-23-2 10mg $139 2021-12-16 Buy
Ambeed A1275711 N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine 98+% 195822-23-2 10mg $140 2021-12-16 Buy
Product number Packaging Price Buy
A1275711 1mg $58 Buy
AS711703 5mg $89 Buy
A1275711 5mg $90 Buy
AS711703 10mg $139 Buy
A1275711 10mg $140 Buy

LQZ-7I Chemical Properties,Uses,Production

Biological Activity

LQZ-7I is an inhibitor targeting survivin. It can inhibits survivin dimerization and xenograft tumor growth and induces loss of survivin in the tumor.

in vitro

LQZ-7I has improved cytotoxicity with IC 50 s of 3.1 μM against C4-2 cells and 4.8 μM against PC-3 cells compared with the parent compound LQZ-7.
LQZ-7I (10 μM; 0-6 hours) treatment reduces the expression of survivin. However, LQZ-7I does not reduce the expression of XIAP, CIAP1, and CIAP2. LQZ-7I may be selective to its intended target survivin .

Western Blot Analysis

< tr>
Cell Line: PC- 3 or C4-2 cells
Concentration: 10 μM
Incubation Time: 0-6 hours
Result: Reduced the expression of survivin.

in vivo

LQZ-7I (100 mg/kg; oral gavage every other day for a total of ten treatments) significantly suppresses tumor growth without any notable adverse effect on the mice.

td>
Animal Model: 6-week old male NSG mice
Dosage: 100 mg/kg; 200 μL vehicle (90% corn oil/10% DMSO)
Administration: Oral gavage every other day for a total of ten treatments
Result: Significantly suppressed tumor growth without any notable adverse effect on the mice as indicated by lacking changes in body weight and in wet weight of major organs at the end of the study.

target

Survivin

LQZ-7I Preparation Products And Raw materials

Raw materials

Preparation Products

LQZ-7I Suppliers

Global( 30)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32836 60
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Nanjing Doge Biomedical Technology Co., Ltd
+86-25-58227606 +86-15305155328 sales@dogechemical.com China 4128 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
LEAPCHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 43348 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 57511 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4309 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9707 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8014 62
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136 info@SuperLan-chem.com China 9943 58
LQZ-7I 2,3-Quinoxalinediamine, N2,N3-bis(4-fluorophenyl)- N2,N3-Bis(4-fluorophenyl)quinoxaline-2,3-diamine LQZ7I,inhibit,Survivin,LQZ 7I,Inhibitor,tumor,LQZ-7I,dimerization 195822-23-2